Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
3.680
-0.210 (-5.40%)
At close: Apr 2, 2026, 4:00 PM EDT
3.610
-0.070 (-1.90%)
After-hours: Apr 2, 2026, 7:59 PM EDT
Acurx Pharmaceuticals Employees
Acurx Pharmaceuticals had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,991,635
Market Cap
10.51M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2024 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2023 | 4 | 0 | - | 4 | 0 |
| Dec 31, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Sep 30, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Dec 31, 2021 | 3 | 0 | - | 3 | 0 |
| Mar 31, 2021 | 3 | - | - | 2 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 43 |
| Lunai Bioworks | 29 |
| BioLineRx | 28 |
| Imunon | 25 |
| Soligenix | 16 |
| NewcelX | 15 |
| BioVie | 13 |
| Cellectar Biosciences | 11 |
ACXP News
- 4 days ago - Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors - PRNewsWire
- 21 days ago - Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update - PRNewsWire
- 23 days ago - Why Is Acurx Pharmaceuticals Stock Up Over 105% Today? - Benzinga
- 25 days ago - Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection - PRNewsWire
- 6 weeks ago - Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update - PRNewsWire
- 2 months ago - USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors - PRNewsWire
- 4 months ago - Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals - PRNewsWire
- 5 months ago - Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update - PRNewsWire